This paper was conducted using a broad literature survey encompassing the past 25 years of basic and clinical research publications exploring IL-1 and IL-6 as each pertains to ovarian cancer prognosis, progression, and treatment. The gene discussed is IL1A; the disease is ovarian cancer.